As part of the launch of research and development activities, Tweed Inc., a wholly owned subsidiary of Canopy Growth, has made an initial transfer of cannabis to CSI.
“The current regulatory model has evolved to include non-inhaled forms of legal medical cannabis,” said Bruce Linton, Chairman and CEO of Canopy Growth. “Researching the next logical steps is a way to be ahead of the curve in a fast-paced industry.”
With these approvals, and its collaboration with UHN, CSI intends to develop intellectual property related to extraction processes, methods to produce standardized products and new formulations.
Once developed, CSI
...
Follow us on Instagram
Connect with us on Linkedin